| Yang Jin, MD | |
|
725 Albany St, Shapiro 9, Suite B, Boston, MA 02118-2526 | |
| (617) 638-7480 | |
| (617) 638-7486 |
| Full Name | Yang Jin |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 32 Years |
| Location | 725 Albany St, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235171125 | NPI | - | NPPES |
| 110084156A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 241542 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Shore Medical Center - | Salem, MA | Hospital |
| Boston Medical Center | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Evans Medical Foundation Inc | 7416946546 | 445 |
| North Shore Physicians Group Inc | 3577467224 | 488 |
News Archive
Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, today announced that new research findings, published in the November 2009 issue of the Journal of Perinatology, show that Masimo perfusion index (PI) accurately predicts low superior vena cava flow (SVC) in preterm, very-low-birth-weight infants-representing a promising method for continuous and noninvasive monitoring of systemic blood flow.
CQ Politics: "Speaker Nancy Pelosi said Thursday she wouldn't rule out keeping the House in session for part of Christmas week, if that could lead to final action this year on a health care overhaul. Right now, however, such a scenario appears unlikely." In the Senate, Democratic leaders are waiting for an updated Congressional Budget Office analysis - a report not expected before next week - that includes the most recent round of proposals to the bill they are considering.
Without good models to study cancer metastasis - the spread of cancer cells from one organ to another - cancer researchers have struggled to understand tumor progression fully, and new therapies targeting the main causes of death are slow to come.
Current treatment options for the parasitic disease leishmaniasis are largely ineffective, expensive, and tend to be plagued by resistant parasites and side effects. Now, researchers reporting in PLOS Neglected Tropical Diseases have showed that a natural flavonoid is effective at treating Leishmania amazonensis infections.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has acquired the ex-China global rights to Apexigen's anti-TNF monoclonal antibody ("mAb") technology. 3SBio previously acquired the China rights from Apexigen in 2006.
› Verified 5 days ago
| Entity Name | Evans Medical Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912954124 PECOS PAC ID: 7416946546 Enrollment ID: O20040512000397 |
News Archive
Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, today announced that new research findings, published in the November 2009 issue of the Journal of Perinatology, show that Masimo perfusion index (PI) accurately predicts low superior vena cava flow (SVC) in preterm, very-low-birth-weight infants-representing a promising method for continuous and noninvasive monitoring of systemic blood flow.
CQ Politics: "Speaker Nancy Pelosi said Thursday she wouldn't rule out keeping the House in session for part of Christmas week, if that could lead to final action this year on a health care overhaul. Right now, however, such a scenario appears unlikely." In the Senate, Democratic leaders are waiting for an updated Congressional Budget Office analysis - a report not expected before next week - that includes the most recent round of proposals to the bill they are considering.
Without good models to study cancer metastasis - the spread of cancer cells from one organ to another - cancer researchers have struggled to understand tumor progression fully, and new therapies targeting the main causes of death are slow to come.
Current treatment options for the parasitic disease leishmaniasis are largely ineffective, expensive, and tend to be plagued by resistant parasites and side effects. Now, researchers reporting in PLOS Neglected Tropical Diseases have showed that a natural flavonoid is effective at treating Leishmania amazonensis infections.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has acquired the ex-China global rights to Apexigen's anti-TNF monoclonal antibody ("mAb") technology. 3SBio previously acquired the China rights from Apexigen in 2006.
› Verified 5 days ago
| Entity Name | North Shore Physicians Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588606123 PECOS PAC ID: 3577467224 Enrollment ID: O20050429000668 |
News Archive
Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, today announced that new research findings, published in the November 2009 issue of the Journal of Perinatology, show that Masimo perfusion index (PI) accurately predicts low superior vena cava flow (SVC) in preterm, very-low-birth-weight infants-representing a promising method for continuous and noninvasive monitoring of systemic blood flow.
CQ Politics: "Speaker Nancy Pelosi said Thursday she wouldn't rule out keeping the House in session for part of Christmas week, if that could lead to final action this year on a health care overhaul. Right now, however, such a scenario appears unlikely." In the Senate, Democratic leaders are waiting for an updated Congressional Budget Office analysis - a report not expected before next week - that includes the most recent round of proposals to the bill they are considering.
Without good models to study cancer metastasis - the spread of cancer cells from one organ to another - cancer researchers have struggled to understand tumor progression fully, and new therapies targeting the main causes of death are slow to come.
Current treatment options for the parasitic disease leishmaniasis are largely ineffective, expensive, and tend to be plagued by resistant parasites and side effects. Now, researchers reporting in PLOS Neglected Tropical Diseases have showed that a natural flavonoid is effective at treating Leishmania amazonensis infections.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has acquired the ex-China global rights to Apexigen's anti-TNF monoclonal antibody ("mAb") technology. 3SBio previously acquired the China rights from Apexigen in 2006.
› Verified 5 days ago
| Entity Name | Brigham And Women's Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033535497 PECOS PAC ID: 3870405988 Enrollment ID: O20150107001260 |
News Archive
Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, today announced that new research findings, published in the November 2009 issue of the Journal of Perinatology, show that Masimo perfusion index (PI) accurately predicts low superior vena cava flow (SVC) in preterm, very-low-birth-weight infants-representing a promising method for continuous and noninvasive monitoring of systemic blood flow.
CQ Politics: "Speaker Nancy Pelosi said Thursday she wouldn't rule out keeping the House in session for part of Christmas week, if that could lead to final action this year on a health care overhaul. Right now, however, such a scenario appears unlikely." In the Senate, Democratic leaders are waiting for an updated Congressional Budget Office analysis - a report not expected before next week - that includes the most recent round of proposals to the bill they are considering.
Without good models to study cancer metastasis - the spread of cancer cells from one organ to another - cancer researchers have struggled to understand tumor progression fully, and new therapies targeting the main causes of death are slow to come.
Current treatment options for the parasitic disease leishmaniasis are largely ineffective, expensive, and tend to be plagued by resistant parasites and side effects. Now, researchers reporting in PLOS Neglected Tropical Diseases have showed that a natural flavonoid is effective at treating Leishmania amazonensis infections.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has acquired the ex-China global rights to Apexigen's anti-TNF monoclonal antibody ("mAb") technology. 3SBio previously acquired the China rights from Apexigen in 2006.
› Verified 5 days ago
| Entity Name | Incare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639655467 PECOS PAC ID: 1153658851 Enrollment ID: O20190802001626 |
News Archive
Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, today announced that new research findings, published in the November 2009 issue of the Journal of Perinatology, show that Masimo perfusion index (PI) accurately predicts low superior vena cava flow (SVC) in preterm, very-low-birth-weight infants-representing a promising method for continuous and noninvasive monitoring of systemic blood flow.
CQ Politics: "Speaker Nancy Pelosi said Thursday she wouldn't rule out keeping the House in session for part of Christmas week, if that could lead to final action this year on a health care overhaul. Right now, however, such a scenario appears unlikely." In the Senate, Democratic leaders are waiting for an updated Congressional Budget Office analysis - a report not expected before next week - that includes the most recent round of proposals to the bill they are considering.
Without good models to study cancer metastasis - the spread of cancer cells from one organ to another - cancer researchers have struggled to understand tumor progression fully, and new therapies targeting the main causes of death are slow to come.
Current treatment options for the parasitic disease leishmaniasis are largely ineffective, expensive, and tend to be plagued by resistant parasites and side effects. Now, researchers reporting in PLOS Neglected Tropical Diseases have showed that a natural flavonoid is effective at treating Leishmania amazonensis infections.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has acquired the ex-China global rights to Apexigen's anti-TNF monoclonal antibody ("mAb") technology. 3SBio previously acquired the China rights from Apexigen in 2006.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yang Jin, MD 720 Harrison Ave, Dob 503, Boston, MA 02118-2371 Ph: () - | Yang Jin, MD 725 Albany St, Shapiro 9, Suite B, Boston, MA 02118-2526 Ph: (617) 638-7480 |
News Archive
Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, today announced that new research findings, published in the November 2009 issue of the Journal of Perinatology, show that Masimo perfusion index (PI) accurately predicts low superior vena cava flow (SVC) in preterm, very-low-birth-weight infants-representing a promising method for continuous and noninvasive monitoring of systemic blood flow.
CQ Politics: "Speaker Nancy Pelosi said Thursday she wouldn't rule out keeping the House in session for part of Christmas week, if that could lead to final action this year on a health care overhaul. Right now, however, such a scenario appears unlikely." In the Senate, Democratic leaders are waiting for an updated Congressional Budget Office analysis - a report not expected before next week - that includes the most recent round of proposals to the bill they are considering.
Without good models to study cancer metastasis - the spread of cancer cells from one organ to another - cancer researchers have struggled to understand tumor progression fully, and new therapies targeting the main causes of death are slow to come.
Current treatment options for the parasitic disease leishmaniasis are largely ineffective, expensive, and tend to be plagued by resistant parasites and side effects. Now, researchers reporting in PLOS Neglected Tropical Diseases have showed that a natural flavonoid is effective at treating Leishmania amazonensis infections.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has acquired the ex-China global rights to Apexigen's anti-TNF monoclonal antibody ("mAb") technology. 3SBio previously acquired the China rights from Apexigen in 2006.
› Verified 5 days ago
Kaitlyn My-tu Lam, MBBS Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-724-7738 | |
Kui Toh Gerard Leong, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit Street, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-8862 | |
Ruma Rajbhandari, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-525-6841 | |
Alaka Ray, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2066 | |
Meghan E Sise, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2862 | |
Aaron Dickstein, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Box 233, Boston, MA 02111 Phone: 617-636-5883 Fax: 617-636-9292 | |
Dr. Felicia Elizabeth Patch, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 801 Massachusetts Ave, Crosstown 2, Boston, MA 02118 Phone: 617-414-4376 Fax: 617-414-4676 |